Oscar Health

Oscar Health, Inc. operates as a health insurance company which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Oscar Health reports robust growth and profitability outlook for 2023

Oscar Health's 2022 performance showcased strong growth in membership, improved financial ratios, and a focus on efficiency and profitability in the insurance business.
The company's strengths lie in exceeding targets for capital, stable premiums, and leveraging investment income for competitive advantage.
Challenges include financial transparency and managing risk pool dynamics, while opportunities exist in market expansion, PBM contract benefits, and margin expansion strategies.
Overall, Oscar Health's strategic focus on growth, efficiency, and profitability positions it well for future success in the insurance market.

Oscar Health achieves Q1 profitability, focuses on tech innovation

Oscar Health's Q1 2023 earnings call highlighted strong financial performance, operational efficiency, and a strategic focus on profitability priorities.
While facing challenges such as reshaping strategies and market-specific dynamics, the company is well-positioned to leverage opportunities for growth and innovation.
With a mission-driven approach, a growing member base, and a commitment to enhancing technology, Oscar Health aims to sustain profitability and market competitiveness.

Oscar Health reports strong Q2 earnings, eyes growth opportunities

Oscar Health's Q2 performance reflects positive trends in profitability, membership growth, and strategic planning for future expansion.
While facing challenges in pricing strategies and achieving profitability targets, the company is well-positioned to capitalize on growth opportunities.
With a focus on innovation, customer satisfaction, and market expansion, Oscar Health aims to strengthen its competitive position in the healthcare industry.

Oscar Health excels in Q3, eyes profitability in 2024

Oscar Health's Q3 2023 earnings call highlighted strong performance metrics, a focus on profitability in 2024, and strategic initiatives to drive growth and enhance member satisfaction. While facing challenges in narrowing EBITDA losses, the company remains optimistic about its trajectory and expressed confidence in its strategic direction and employee dedication.

Oscar Health achieves insurance profitability, eyes growth amid market changes

Oscar Health's Q4 2023 Earnings Call highlighted achievements in insurance company profitability and significant improvements in total company adjusted EBITDA.
The company is well-positioned for profitability in 2024, focusing on serving over 1.3 million members with new products and technology enhancements.
Challenges include navigating potential market dynamics changes due to ACA subsidy adjustments, but Oscar Health is proactively addressing these concerns.

Oscar Health posts record revenue and profitability, eyes market expansion

Oscar Health delivered robust Q1 results, showcasing strong revenue growth, improved profitability, and strategic market expansion initiatives.
Despite facing challenges in achieving total company adjusted EBITDA profitability, the company's financial stability and growth prospects remain promising.
With a focus on operational efficiency and long-term strategic vision, Oscar Health is well-positioned to capitalize on market opportunities and drive sustained growth.

Oscar Health reports strong Q2 results, eyes growth through technology

Oscar Health's Q2 2024 earnings call showcased robust financial performance, driven by revenue growth and improved EBITDA. The company's membership expansion and strategic focus on technology-driven engagement are key strengths. Challenges include policy uncertainties and meeting raised guidance, while opportunities exist in market resonance and technological advancements.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Harvard Business School classmates Josh Kushner, Mario Schlosser, and Kevin Nazemi decide to start a company to demystify health insurance.

Oscar, named after Kushner's great grandfather, raises $51.5 million through Series A, AA, and AAA funding from Gary Vaynerchuk, Dave Gilboa, Khosla Ventures, Lerer Ventures, General Catalyst Thrive Capital, Founders Fund, Kal Vepuri, BoxGroup and more, with a pre-money valuation of $70 million.

Series A4 funding drops a nice $30 million from investors into Oscar's wallet, bumping its valuation to $310 million.

Oscar secures $80 million in Series A5 funding, mostly from Formation 8. Pre-money valuation reaches $500 million.

Nearly 150,000 members call themselves Oscar-insured across four states alone (NY, NJ, CA, & TX).

Oscar's member services team sets up camp in Tempe, Ariz.

Mount Sinai Health System partners to open the Oscar Center, offering primary care, mental health, and wellness services to members—sort of like a fancy urgent care. 😎

Oscar offers coverage to New York small businesses for their employees. 

The Cleveland Clinic collab drops in the Midwest market to cover individuals across northeastern Ohio. 

Oscar expands to new regions, including Tennessee, Ohio, Texas, New Jersey, and California.

Hey, y’all: A partnership with Humana helps Oscar cover small businesses up to 50 employees in Nashville, Tenn.

Series G round nets Oscar $165 million in funding, zooming the estimated value to a whopping $3.2 billion.

Alphabet (parent company to Google) decides to invest, cutting Oscar a check for $375 million.

The "Cigna + Oscar" collab brings together Cigna's vast network to Oscar's member-focused experience for small businesses. 

Gary Vaynerchuk and Khosla Ventures go for round 2, but this time, a sweet $225 million with the help of Builders VC.

Tiger Global Management invests $140 million in Oscar, as the company's member count exceeds 400,000.

Oscar begins trading on the New York Stock Exchange under the ticker $OSCR.

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Is Oscar Health (OSCR) a Buy as Wall Street Analysts Look Optimistic?

Oscar Health, Inc. (OSCR, Financial) experienced a significant drop in stock price, plunging 5.04%. The stock is currently valued at $19.23 per share with a trading volume of 1.242 million shares, reflecting a turnover rate of 0.51% and a price fluctuation amplitude of 6.07%.

Oscar Health (OSCR) Stock Dips Amidst Volatile Trading Session

Shares of Oscar Health Inc (OSCR, Financial) fell 3.10% in mid-day trading on Oct 2. The stock reached an intraday low of $19.22, before recovering slightly to $19.99, down from its previous close of $20.63.

Oscar Health Inc (OSCR) Stock Price Down 3.1% on Oct 2

In the closing of the recent trading day, Oscar Health, Inc. (OSCR) stood at $21.21, denoting a +1.05% change from the preceding trading day.

Oscar Health, Inc. (OSCR) Surpasses Market Returns: Some Facts Worth Knowing

The trade gives a break-even price of 20.30.

Oscar Health Stock Today: Cash Secured Put May Lower Cost Of Ownership Or Return 10.8%

GitLab

Seagate Technology Holdings PLC

Tom Yeung here with your Sunday Digest.  Last week, I wrote about “Gravity Pleasure Road,” the world's first modern roller coaster with a built-in lift hill that could pull cars back up a slope.

3 More AI Stocks to “Buy the Dip”

Oscar Health (OSCR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Strength Seen in Oscar Health (OSCR): Can Its 18.7% Jump Turn into More Strength?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Brokers Suggest Investing in Oscar Health (OSCR): Read This Before Placing a Bet

Assurant

Investors looking for stocks in the Insurance - Multi line sector might want to consider either Assurant (AIZ) or Oscar Health, Inc. (OSCR). But which of these two stocks presents investors with the better value opportunity right now?

AIZ or OSCR: Which Is the Better Value Stock Right Now?

NEW YORK--(BUSINESS WIRE)--Oscar Health to Present at Upcoming Healthcare Conferences.

Oscar Health to Present at Upcoming Healthcare Conferences

AIZ vs. OSCR: Which Stock Is the Better Value Option?

Oscar Health, Inc. (NYSE:OSCR ) Q2 2024 Earnings Conference Call August 7, 2024 8:00 AM ET Company Participants Chris Potochar - VP, Treasury and IR Mark Bertolini - CEO Scott Blackley - CFO Conference Call Participants Steve Baxter - Wells Fargo Jessica Tassan - Piper Sandler Joshua Raskin - Nephron Research Adam Ron - Bank of America Olivia Miles - Baird Operator Good morning, everyone. My name is Ellie, and I will be your conference operator for today.

Oscar Health, Inc. (OSCR) Q2 2024 Earnings Call Transcript

Oscar Health, Inc. (OSCR) came out with quarterly earnings of $0.20 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to loss of $0.07 per share a year ago.

Oscar Health, Inc. (OSCR) Q2 Earnings and Revenues Surpass Estimates

AppLovin Corp

Emerson Electric

IAMGOLD

MediaAlpha

Newmont Mining

Pan American Silver

Growth stocks may not be the first thing on your mind right now, and I get it. Most growth plays are tied to tech or software, sectors that have faced immense pressure amid recession fears and a brutal tech selloff sparked by Big Tech's disappointing results.

7 Promising Growth Stocks Set to Skyrocket in 2025

Oscar Health Wednesday reported $56 million in net income – its second quarterly profit in the company's 12-year history – as the provider of individual coverage under the Affordable Care Act grows its health plans for consumers and employers.

Another Profitable Quarter For Oscar Health As Obamacare Business Grows

NEW YORK--(BUSINESS WIRE)--Oscar Health Announces Results for Second Quarter 2024 and Raises Full Year Revenue and Adjusted EBITDA Outlook.

Oscar Health Announces Results for Second Quarter 2024 and Raises Full Year Revenue and Adjusted EBITDA Outlook

Oscar Health's (OSCR) Q2 results are likely to reflect membership growth, prudent pricing and improved cost-of-care initiatives.

Is a Beat in Store for Oscar Health (OSCR) in Q2 Earnings?

Oscar Health (OSCR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Oscar Health, Inc. (OSCR) Reports Next Week: Wall Street Expects Earnings Growth

Here is how Oscar Health, Inc. (OSCR) and Acadia Realty Trust (AKR) have performed compared to their sector so far this year.

Is Oscar Health (OSCR) Stock Outpacing Its Finance Peers This Year?

Blue Bird

ZTO Express

Funding high-growth stocks is a critical strategy to achieve significant returns in a recovering market. Here, the focus is on three high-growth stocks positioned to double investment within the next two years.

3 Stocks With the Potential to Double Your Money in 2 Years

The latest trading day saw Oscar Health, Inc. (OSCR) settling at $16.19, representing a +1.19% change from its previous close.

Oscar Health, Inc. (OSCR) Exceeds Market Returns: Some Facts to Consider

Oscar Health, Inc. (OSCR) closed the most recent trading day at $16.59, moving +1.22% from the previous trading session.

Oscar Health, Inc. (OSCR) Ascends While Market Falls: Some Facts to Note

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar” or the “Company”) (NYSE: OSCR), a leading healthcare technology company, will release its second quarter 2024 financial results before the market opens on Wednesday, August 7, 2024. Management will review these results in a conference call beginning at 8:00 AM (ET). The call-in number and webcast link are as follows: Live Call: (888) 596-4244 Conference ID: 776-8132 Webcast Link The call will be archived and available on Oscar's investor re.

Oscar Health, Inc. 2024 Second Quarter Conference Call

Here is how Oscar Health, Inc. (OSCR) and Palomar (PLMR) have performed compared to their sector so far this year.

Is Oscar Health (OSCR) Outperforming Other Finance Stocks This Year?

Gigacloud Tech

PayPal

For those hoping to profit from future development, figuring out which prospective tech stocks to buy is essential in the ever-changing world of investing prospects. These three exceptional businesses represent tenacity, inventiveness, and strategic vision in their respective fields.

News for Oscar Health Stock (OSCR)